Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07146815
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:23.757450+00:00
Published At
2025-08-28T00:00:00+00:00
Record Updated At
2025-08-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["NAFLD (Nonalcoholic Fatty Liver Disease)", "Polycystic Ovarian Syndrome (PCOS)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-28"
protocolSection.identificationModule.nctId
"NCT07146815"
protocolSection.identificationModule.officialTitle
"PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • NAFLD (Nonalcoholic Fatty Liver Disease) (protocolSection.conditionsModule.conditions)
  • Polycystic Ovarian Syndrome (PCOS) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.